Pediatric Obesity: Looking into Treatment by Pietrobelli, Angelo et al.
Nutrients 2009, 1, 197-209; doi:10.3390/nu1020197 
 
 
nutrients 
ISSN 2072-6643 
www.mdpi.com/journal/nutrients 
Review  
Pediatric Obesity: Looking into Treatment 
 
Angelo Pietrobelli 
1,2,*, Simone Rugolotto 
1, Paolo De Cristofaro 
3 and Marcella Malavolti 
2 
 
1  Pediatric Unit, Verona University Medical School, Verona, 37134 Italy;  
E-Mail: rugolotto@hotmail.com 
2   Applied Dietetic Technical Sciences Chair, Modena and Reggio Emilia University, Modena, 40100 
Italy; E-Mail: marcella.malavolti@unimore.it 
3  Centro Regionale di Fisiopatologia della Nutrizione ASL Teramo, Giulianova 64022 Italy; 
E-Mail: pdecristofaro@gmail.com 
 
* Author to whom correspondence should be addressed: E-Mail: angpie@tin.it;  
Tel.: +39-045-812-4390; Fax: +39-045-812-4746. 
Received: 30 October 2009 / Accepted: 23 November 2009 / Published: 30 November 2009 
 
Abstract:  Prevalence of pediatric obesity continues to rise worldwide. Increasing the 
number of health care practitioners as well as pediatricians with expertise in obesity 
treatment is necessary.  Because many obese patients suffer obesity-associated 
cardiovascular, metabolic and other health complications that could increase the severity of 
obesity, it is fundamental not only to identify the child prone to obesity as early as 
possible, but to recognize, treat and monitor obesity-related diseases during adolescence. 
This short review outlines the treatment of pediatric obesity that may have applications in 
the primary care setting. It examines current information on eating behavior, sedentary 
behavior, and details studies of multidisciplinary, behavior-based, obesity treatment 
programs. We also report the less common and more aggressive forms of treatment, such 
as medication and bariatric surgery. We emphasize that health care providers have the 
potential to improve outcomes by performing early identification, helping families create 
the best possible home environment, and by providing structured guidance to obese 
children and their families. 
Keywords:  children; adolescents; nutritional assessment; cardio-vascular risk factors; 
adiposity; physical activity; lifestyle changes 
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1. Introduction  
 
The causes of pediatric obesity are both genetic and environmental [1]. Twin studies have clearly 
demonstrated the genetic link, and the discovery of hormones that influence appetite, satiety and fat 
deposition provide the underlying metabolic mechanisms giving rise to different physiologic risks of 
obesity [1,2]. To allow the development of obesity, both genetic and environmental factors must 
influence one or more components of energy balance. At the population level, the increase in 
prevalence is too rapid to be explained by a genetic shift, but it is more related to changes in eating and 
physical activity, behaviors that alter the balance of energy intake and energy expenditure [2-4].  
Epidemiologic evidence supports the theory that the relation between obesity and disease risk 
begins early in life, and those risk factors for disease track, or remain at a similar level, with advancing 
age, growth, and development [1-4].  
The classification of obesity and overweight are age- and gender-specific and are defined on the 
basis of Body Mass Index (BMI, calculated as weight in kilograms divided by the square
 of height in 
meters, kg/m
2) normative values that were established when the distribution of BMI values was 
constant [5]. The definition of overweight among children is a statistical
 definition based on the 2,000 
Centers for Disease Control and
 Prevention growth charts for the United States.
 Overweight
 is defined 
as at or above the 95
th percentile of BMI for age. At risk for overweight is defined
 as at or above the 
85th percentile, but less than the 95th percentile
 of BMI for age [5]. The increase in obesity prevalence 
is therefore measured against a stable cutoff point, the 95
th percentile BMI for gender and age. 
On the basis of measured height and weight from nationally representative samples of US children 
assessed approximately every five years, obesity prevalence has increased from 5% in 1963 to 1970 to 
17% in 2003 to 2004 [6]. Recently using a nationally representative sample, it was reported in USA 
that the prevalence of overweight has increased, among children 6 to 24 months of age, from 7.2% in 
1976–1980 to 11.6% in 1999–2000 [2].  
Overweight and obese subjects have a greater risk of developing cardiovascular risk factors, such as 
hypercholesterolemia, hypertension, and hyperlipidemia. Overweight subjects also have a higher risk 
of developing type 2 diabetes, obstructive sleep apnea, orthopedic complications, renal diseases, and 
metabolic syndrome [2,3,6]. Fat tissue, once considered as an inert depot for energy storage, is now 
seen as metabolically active. Fat cells secrete agents that regulate a host of physiologic processes 
directly related to carbohydrate and fat metabolism and the development of cardiovascular disease and 
type 2 diabetes [3,4]. Being overweight also has a negative impact on subjects’ psychological state that 
could be a reflection of body dissatisfaction and binge-eating behaviors [2].  
Although pediatricians are concerned with the problem of pediatric obesity, most feel unprepared 
and ill equipped to address it [7]. A survey of pediatricians, dieticians, and pediatric nurse 
practitioners, confirm that pediatricians do indeed face many challenges in treating childhood   
obesity [8]. Most pediatric primary care providers are not trained to offer the extensive counseling 
required to treat obesity. Most have insufficient time to dedicate to the obese child. Pediatricians may 
also be frustrated by what they see as insufficient patient motivation and lack of parental concern [7].  
Because the high and rising prevalence of obesity among children is a key concern a strong stance 
needs to be taken. In order to improve the quality of health care and to minimize cost it is important to 
investigate and standardize pediatric obesity prevention and treatment and to adapt to it to both social Nutrients  2009, 1                                       
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and cultural aspects.  This approach will make it easier for health care personnel to help patients  
and families.  
The enormous cost of obesity and its complications, particularly when initiated in childhood, 
emphasizes the importance of treating childhood obesity at its inception [9,10]. Surprisingly, little 
evidence-based, high quality research has been carried out on identifying interventions to treat 
childhood obesity. This review will provide a synopsis of treatments that have been evaluated in 
appropriate studies. It will put particular emphasis on novel approaches and as such will consider 
papers mainly published in the last five years. The worsening obesity epidemic makes it critical to 
continue examining and developing new and more effective treatment strategies with the goal of a 
coordinated approach involving government, communities, and health-care providers to offer a 
continuum of population-based interventions, focused screening, and personalized multidisciplinary 
interventions for the obese child and their family [10-12].  
 
Treatment choice 
 
Many different treatments have been investigated, including diet, exercise, surgery and medication. 
None have been found to be effective as a sole treatment. Several studies have been performed in more 
lab-oriented setting, while others have focused on free living conditions [8,9,11-13]. It is clear that 
treatments need to be both affirmative and long lasting. Single physical treatments are ineffective as 
they fail to take into account related psychological factors and the lifelong influence of   
genetics [9,10,13]. The necessity of implementing “chronic” treatment results from an increasing 
knowledge of genetics, where an inherited susceptibility to develop obesity has been identified. Thus, 
a lifelong treatment program of exercise and diet is required.  
Ultimately, the goal of obesity treatment is the improvement of long-term physical health through 
permanent changes towards a healthy lifestyle. Implicit in this approach is that clinicians, patients and 
parents work together. In fact, the commitment of parents and other caregivers in helping a child to 
develop healthy habits to treat obesity is fundamental [8,13].  
 
Proposition for a treatment program 
 
Based on recent reports [8,11-13] on prevention, assessment and treatment of obesity a step by step 
or staged approach for weight management in the pediatric population is highly recommended. The 
recommended care process according to the Expert Committee of American Academy of Pediatric is 
divided into four stages, (1) prevention with the goal of healthy lifestyle changes, (2) structured weight 
management, (3) comprehensive multidisciplinary intervention, and (4) tertiary care intervention/ 
treatment [13].  
Stage 1, the prevention stage, provides an initial treatment intervention useful for patients 2 to 18 
years of age that are overweight or obese. The interventions should be based on the family’s readiness 
to change and include the following aims: (i) consumption of ≥5 servings of fruits and vegetables per 
day, (ii) reduction or elimination of sweetened beverages, (iii) reduction of TV or video games 
(“screen time”) to 2 hours per day with no television in the child’s bedroom, and (iv) at least one hour 
of physical activity per day. Patients and family members also have to follow set eating patterns. Nutrients  2009, 1                                       
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Specifically: (i) eating breakfast daily, (ii) limiting meals outside home, including fast food venues, 
(iii) eating family meals once a day. Cultural difference related to eating behaviors must be taking into 
consideration [9]. The goal should be weight maintenance with growth that results in a BMI reduction 
as age and height increase. If no improvement of BMI reduction occurs after approximately 6 months, 
advancement to Stage 2 is highly recommended, keeping in mind patient/family readiness to   
change [9,13].  
Stage 2, structured weight management, recommends the following: (i) development of a plan with 
a balanced diet and small amounts of energy-dense foods, (ii) provision of structured daily meals and 
appropriate snacks (i.e., breakfast, mid-morning snack, lunch, mid-afternoon snack and dinner),   
(iii)  ≥1 hour of structured active play per day, (iv) ≤1 hour of daily “screen” use, (v) increased 
behavior monitoring of all the structured activities (i.e., diet, activity, screen time use), (vi) 
reinforcement for achieving targeted behavior goals, but no mention of weight goals to the patient, 
particularly adolescents, should be made . In Stage 2, for subjects in the 85
th–94
th percentile with 
health risks, the goal should be weight maintenance resulting in a BMI decrease as age and height 
increase. In this stage, in subjects in the 95
th–99
th percentile it is suggested weight loss should be 
gradual (0.5 kg/month), while in subjects >99
th percentile, weight loss should not exceed 
approximately 1 kilogram per week. If no improvement in BMI status occurs in 3 to 6 months, the 
patient needs to be advanced to Stage 3. Ideally in Stage 2, a dietician with expertise in childhood 
obesity should provide the nutrition counseling as well as an exercise physiologist to provide physical 
activity counseling both in conjunction with the primary care provider. Additional training in 
motivational interviewing/behavioral counseling, monitoring and reinforcement, family conflict 
resolution could help primary care providers to implement treatment [9,13,14]. Parents should be 
involved in behavioral modification and sometimes a referral to a physical activity program for the 
entire family may be necessary to help some families to develop an active lifestyle [9,13].  
Stage 3, provides a comprehensive multidisciplinary intervention, eating and activity goals remain 
the same as in Stage 2. Activities within this category should also include the following: (i) planned 
negative energy balance achieved through structured diet and physical activity, (ii) structured behavior 
modification program including the development of short-term goals, (iii) provision of training for the 
whole family to improve the home environment, (iv) frequent clinic visits, with weekly visits for the 
first 8 to 12 weeks [13]. Systematic, specific and rigorous body composition assessment should be 
conducted at baseline and at specific intervals in order to control changes in fat and fat free mass 
development [15]. Because BMI is a surrogate measurement of adiposity, waist circumference should 
be used to detect visceral adiposity and subsequent cardio vascular risk factors. [4,8,13,15]. 
Bioimpedance analysis (BIA) should also be used to estimate lean and fat mass [15]. For Stage 3, the 
goal should be weight maintenance or gradual weight loss until BMI is <85
th percentile [13]. For 
implementation of the intervention, comprehensive treatment should be provided by a 
multidisciplinary obesity care team, including psychologist, registered dietician/nutritionist, exercise 
physiologist [9,13,15]. The primary care provider should continue to monitor medical issue and 
maintain a strong supportive alliance with the family [13]. 
Stage 4, tertiary care intervention/treatment should be used to only a limited extent in the pediatric 
population. It is appropriate for severely obese adolescents who have been unable to decrease their 
adiposity and reduce their morbidity risks [13]. Before entering the Stage 4 intervention patients Nutrients  2009, 1                                       
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should have the maturity to understand the possible associated risks. Patients should be willing to 
maintain physical activity, to follow a diet and to participate in behavior monitoring. Stage 4 should 
include referral to a pediatric tertiary management center that operates with a designed protocol that 
considers meal replacement, very-low-energy diet, medication and ultimately bariatric surgery [13]. A 
restrictive diet should be used as a first step in a childhood weight management program, followed by 
a mildly restrictive diet. Stage 4 considers the use of drug treatment as well as surgery [2,8,13]. For 
implementation of Stage 4, the multidisciplinary team should have expertise in childhood obesity and 
its co-morbidities, with patient care being provided by a physician, nurse practitioner, a registered 
dietitian, a behavior counselor, and an exercise specialist.  
In conclusion, the role of family in weight control programs cannot be emphasized strongly enough. 
Parents can serve as role models, authority figures, and “behavioralists” to mold their children’s eating 
and activity habits [8,10,13]. Clinicians can influence children’s habits indirectly by teaching and 
motivating parents to use their authority effectively. For young children the clinicians should focus 
their attention on parenting behavior. With adolescents, due to increasing independence, clinicians 
should discuss healthy behaviors directly with them, but encourage parents to make the home 
environment as healthy as possible [8,16]. 
 
Why do we need new treatments? 
 
Many different treatments for obesity have been investigated, including diet, exercise, surgery and 
medication. None have been found to be effective as stand alone treatments. It is clear that treatment 
needs to be affirmative and long-term. The necessity for chronic treatment is more widely recognized 
due to increased knowledge of genetics, where many obese patients have an inherited susceptibility to 
develop obesity. Thus, obese patients need lifelong treatment and not merely a short period of exercise 
or a diet program [8,9,11,12]. When a patient is identified as having an inherited predisposition to 
obesity, an extremely healthy lifestyle is necessary to maintain normal body weight [1,9,11]. Below a 
number of strategies in the treatment of childhood obesity are outlined.  
 
Basic approach – school-based treatments 
 
At school behavioral therapy can be used including behavior modification, nutrition modification 
and physical activity. Parents and school personnel should all be involved. Implementing the treatment 
at school promotes a healthy lifestyle to all children and it can be a fruitful approach. However, long 
term follow-up is not easy in such studies because so many variables have to be controlled for. This 
approach has been reviewed but with no single “specific” program being identified as better than 
others and for this reason, no recommendation could be made [8,9]. Interventions must consider the 
powerful influences of the social context on treatment approaches and the theoretical basis for their 
use. Healthy lifestyle education should be delivered to students in structured, educational settings with 
peer support and teacher guidance. It is within the school setting that children are socialized to accept 
the standards and values of their society and is an ideal setting for promotion of new health   
behaviors [17]. Nutrients  2009, 1                                       
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Early treatment 
 
Public health researchers have traditionally described three types of prevention for overweight and 
obesity: primary, secondary and tertiary prevention [8]. Primary prevention is where the medical 
condition is prevented through early and aggressive intervention. Ideally, intervention completely 
preempts or interrupts the emergence of the condition even before its early stages. Thus, primary 
prevention of pediatric obesity requires early-life detection of excessive adiposity or the identification 
of genetic markers to target individuals who will probably become obese if left untreated [1,8].  
Treatment that starts before the major peak incidence of pediatric obesity should show positive 
results. It is similar to school based treatment, but differs because it is directed at obese   
children [8-10,13]. Such early treatment could prevent severe cases of obesity in adulthood. The 
primary goal of obesity treatment is improvement of long-term physical health through permanent 
healthy lifestyle habits [8,13]. The establishment of permanent healthy lifestyle habits is a good 
outcome, regardless of weight change, because of the long-term health benefits of these behaviors. 
 
Behavior therapy 
 
The program is based on the concept that obesity is a “learned disease” that can be treated by “re-
learning”. The therapy is based on the concept of bad eating habits in which an insufficient control of 
stimulus or rewarding behavior results in increased food intake. These habits can be broken down into 
small sequences. Parents are regarded as a reinforcement of the subject’s eating habits. The purpose of 
the behavior assessment is twofold. The first goal is to identify the child’s dietary and physical activity 
behaviors that promote positive energy balance and that are modifiable [8,13,18]. The second goal of 
the patients together with their family is to change some and/or all these behaviors [8,13,18]. The 
clinicians should work with the family to target behavior changes that are possible. Because 
comprehensive dietary and physical activity assessment are impractical expert committees recommend 
an assessment of behaviors that have evidence for association with energy balance and that are 
modifiable [8,13].  
For eating behavior assessment it is fundamental to address frequency of eating outside the home, 
the number of sugar-sweetened beverages consumed per day, portion sizes, frequency of breakfast, the 
number of fruit and vegetables and the number of meals and snacks consumed each day as well as 
consumption of foods that are high in energy density. For physical activity assessment it is important 
to know the time spent in moderate physical activity, routine daily activities and sedentary behavior. 
When inappropriate dietary and physical activity behaviors are detected, the primary care provider 
should provide support and guidance for both healthy eating and activity habits according to 
recommendations [2,7,8,11,13]. It is important to achieve the targeted behaviors in steps. This is 
particularly true for physical activity, starting with 15 minutes physical activity per day and so on up to 
60 minutes.  
 Nutrients  2009, 1                                       
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Cognitive behavior therapy 
 
This therapy has been used recently in the treatment of obesity usually combined with behavioral 
therapy. The combination is based on the assumption that, through practice and reward, changes in key 
areas of children’s cognitive processing will result in behavior changes [9].  
The family is regarded as basic to the child’s psychological development and a major factor 
influencing the child’s quality of life. Family therapy in treating obese subjects in conjunction with 
healthy diet and physical activity has shown obesity reduction in older teenagers if treatment is started 
as early as possible [9]. In practice, family therapy could be defined as follows: using the encounter 
with a family to improve the obese member’s health by observing and analyzing interaction between 
family members, and also with therapists, and improving their ability to use their own resources [18]. 
 
More aggressive interventions 
 
Weight loss medications in the treatment of pediatric obesity  
 
The use of weight loss medications in adult obesity treatment should be considered for intensive 
regimens. Pharmacotherapy alone has not proved to be an effective obesity treatment. Medication used 
in conjunction with lifestyle modification produce an average weight loss of 5% to 10%, which 
typically plateau at 4 to 6 months of therapy, after which weight regain may occur [8,11,13]. Few 
guidelines are available regarding the use of weight loss medication in the pediatric population. 
Recently Freedman and colleagues [19] using cross-sectional and longitudinal analyses to assess risk 
factors, concluded that 99
th percentile of BMI for age may be an appropriate threshold for identifying 
children and adolescents who are at very high risk for biochemical abnormalities and are ultimately 
candidates for pharmacotherapy [19]. Presently among the approved drugs for adults only 2, orlistat 
and sibutramine, have been approved for limited use in pediatric patients. The Food and Drug 
Administration has approved sibutramine for patients’ ≥16 years of age and orlistat for patients’ ≥12 
years of age. 
Sibutramine, an appetite suppressant, is a non-selective reuptake inhibitor, mainly of serotonin and 
norepinephrine but also blocks dopamine re-uptake [8,11,13]. A 1-year, multi-center study on 498 
adolescents 12 to 16 years of age found that those who received sibutramine plus behavior therapy lost 
significantly more weight than did those who received a placebo and behavior therapy [20]. Subjects 
on the sibutramine group lost an average of 6.35 kg during the study, whereas those in the placebo 
group gained 1.8 kg. The subjects in the drug group also showed significant decreases in insulin as 
well as triglyceride levels. Serious side effects, such as hypertension and tachycardia were reported in 
19 out of 43 adolescents. Godoy-Matos and colleagues studied the safety and efficacy of sibutramine 
in a double-blind control study in 60 obese adolescents and found an average weight loss of 8.1 kg at 6 
months, but did not find any changes in blood pressure [21]. Although, all investigators involved in 
these trials, concluded that more research is required to determine long term efficacy and safety of this 
drug in adolescents [20,21]. In future tests using sibutramine in obese adolescents different strategies 
should be tested such as the introduction of sibutramine after a period of weight control with lifestyle 
changes in order to reduce the potential for side effects such as hypertension.  Nutrients  2009, 1                                       
 
204
Orlistat is a reversible lipase inhibitor. It binds lipase in the lumen of the stomach and cuts 
intestinal fat absorption by up to 30%. The side effects of orlistat are abdominal cramp and flatus [22]. 
The most troubling side effects are oily bowel movements, flatus with discharge, and oily spotting on 
underwear caused by unabsorbed fat in the feces [21]. Orlistat does not inhibit other intestinal enzymes 
and it is minimally absorbed and exerts no effect on systemic lipases [22]. Because it can interfere with 
the absorption of fat-soluble vitamins, patients taking the drug must also take a daily   
supplement [8,13,22]. A multi-center, one-year randomized, placebo-controlled trial in 539 obese 
adolescents 12 to 16 years of age found that those who used orlistat lost weight and had significantly 
greater reductions in BMI (−0.55 kg/m
2), whereas those taking a placebo showed a slight increase in 
BMI (+0.31 kg/m
2). Changes in waist circumference was found in the treatment group (−1.33 cm) 
while the placebo group showed an increase (+0.12 cm, p < 0.05). Although, no significant differences 
in blood glucose or lipid levels was seen in the two groups [22]. The explanation for the failure of lipid 
and glucose levels to improve could be that the body weight loss was too small to change metabolic 
risk factors [22]. This study was not able to identify how much BMI must be reduced to provide health 
benefits and cardio-vascular risks reduction in children and adolescents.  
More than 120 potential drugs for treatment of obesity are currently in various stages of research, 
but presently no agent that treats obesity as a single therapy is available. A lot is known regarding the 
molecular mechanisms regulating body fat and the central regulation of energy balance. In this regard 
it is possible to develop more effective medication. Although medication should be used only as part 
of a multimodal weight management approach that includes diet, physical activity and   
behavior modification.  
 
Bariatric Surgery  
 
Severe obesity has proved difficult to treat through diet and lifestyle changes even with the addition 
of pharmacotherapy. The increased use of bariatric surgery to treat adult morbid obesity and associated 
co-morbidities has led to interest in using this therapy in adolescents. Usually, in adults surgery is 
performed only in patients that are severely obese (BMI > 40) or when they have a BMI > 35 together 
with severe obesity-related health complications [11]. Bariatric weight loss procedures can be divided 
into three categories, that is, malabsorptive, restrictive and a combination of the two. Combination 
procedure such as Roux-en-Y gastric bypass, restrict food intake and reduce/limit the amount of 
nutrients the body absorbs. Gastric bypass procedures are the only form of bariatric surgery currently 
approved for use in adolescents. Sugerman and colleagues reported retrospective data regarding 
surgery procedures in adolescents and found significant weight loss with subsequent resolution of most 
co-morbid conditions [23]. Apovian and colleagues reviewed data of weight loss surgery in 
adolescents between 1980 and 2004. They found a durable weight loss for the majority of the patients. 
Although, they found important post surgery complications and mortality rates [24]. Nadler and 
colleagues showed in 53 obese adolescents that adjustable gastric banding represents an effective 
treatment strategy for excess weight at 18 months [25] and at 2 years of follow-up [26].  
Bariatric surgery generally leads to substantial weight loss and improvement in medical conditions. 
However, peri-operative risks, post-procedure nutritional risks, and the need for lifelong commitment 
to altered eating make this approach unattractive or inappropriate for adolescents [8,13]. After surgery Nutrients  2009, 1                                       
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it is fundamental to maintain lifelong medical supervision to ensure optimal post-operative weight loss, 
and ultimately overall health.      
 
Proposition for a practical treatment program 
 
The recommendations below are not yet “approved”, but have been extrapolated from guidelines 
and previously published papers [8,9,11-13]. Children should not have any signs of other diseases; 
usually overweight and obese subjects are tall for their age and gender. Basic pediatric evaluation 
should include blood pressure measurement, lipid profile control and thyroid function needs to   
be checked.  
 
Age 0–3 years 
 
No action in particular related to weight loss is recommended. 
 
Age 4–10 years 
 
In children with a BMI > 30 and both parents with a BMI < 30. Firstly, it is fundamental to exclude 
syndromic obesity. When this is excluded, it is important to ascertain the dietary intake of the child, 
and provide guidance to the parents with regard to fat intake, reducing the fat content of the diet to 
30% energy around 1500 kcal a day. In children with a BMI > 30 with one or both parents with a  
BMI > 30. The child must be carefully evaluated by the pediatrician with regard to the child’s growth 
chart and encouraged to participate in sport and exercise. A healthy lifestyle approach involving the 
entire family is needed with clear goals provided.  
 
Age 10–16 years 
 
At this age puberty occurs together with changes in hormonal profiles. In a patient with a BMI 
between 25 and 30, parents should be advised to reduce the fat content of the diet to 30% energy and 
the child encouraged to participate in sport and exercise. In patients with BMI > 30 they must be 
referred to a pediatrician with strong recommendations to modify the lifestyle of the family as a whole 
including participation in sport and exercise. 
 
2. Discussion 
 
The key to successfully treating childhood overweight and obesity ultimately lies in developing and 
funding a targeted research agenda. At the top of that agenda should be basic research into the biology 
and physiology of appetite regulation during each developmental stage of childhood. Research should 
also focus on the mechanisms that regulate body fat distribution during adolescence as well as the 
influence of gender and ethnicity on body composition and fat differentiation [1,3]. 
The lack of a clear program to address the precise needs of overweight and obese children has 
emerged in this review. Several gaps in our knowledge are of concern because (a) the pre-school years Nutrients  2009, 1                                       
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may be a critical period for the prevention of obesity as indicated by the association of adiposity 
rebound and obesity in later years; and (b) although the growing prevalence of obesity affects males 
and females equally, males may be more vulnerable to associated health risks such as cardiovascular 
disease [27]. Other issues include a limited number of interventions in home and community settings 
and a lack of pediatric population-based interventions. The short duration of most programs limits the 
possibility of evaluating the effectiveness of interventions [27]. Schools may be a key setting for 
programming where health status indicators, such as body composition, chronic disease risk factors 
and fitness, can all be positively impacted. Engagement in physical activity is a critical intervention in 
obesity prevention. Programs require sustained long-term resources to facilitate comprehensive 
evaluation that will ascertain if long-term impact such as sustained normal weight is maintained. 
Furthermore, involving stakeholders in program design, implementation and evaluation is crucial to 
the success of interventions, helping to ensure that needs are met [27]. Further research is required to 
understand the merits of the forms in which interventions are delivered and in which circumstances 
they are effective. There is a critical need for the development of consistent indicators to ensure that 
comparisons of program outcomes can be made to better inform best practice. 
Age is a major factor that influences the specific strategies chosen helping the overweight and obese 
patient to control his/her weight. It is clear that at preschool age, prevention is more important than 
treatment, but later on treatment becomes necessary. In pre-school children it is easier to set up a 
treatment involving the family, in adolescents this approach will be less successful. We also have the 
impression that learning to adopt a healthy lifestyle, comprising of both diet and exercise, during 
childhood is easier than attempting to change these factors later in life [2,9,10,13]. Early treatment 
prevents the progression of overweight to severe obesity and related cardio-vascular risk factors. It is 
fundamental to continue to a full program of prevention and treatment rather than solely diet or only 
physical activity. It will be only with lifestyle changes that we could have the “unique” opportunity of 
controlling the “obesity epidemic”.  
 
Future Perspectives 
 
-  Given the magnitude of the childhood obesity problem, pediatricians and other health care 
providers need to take a major role in the care of health of the obese child. 
-  Successfully treating obesity will require a major shift in pediatric care. 
-  The most effective way to prevent complications of obesity in teenagers is to introduce and 
reinforce healthy behavior and lifestyle early in childhood. 
-  More clinical studies on the efficacy of specific prevention and treatment programs; and the 
effort to move from efficacy to broad effectiveness are needed. 
 
Executive Summary 
-  Evaluating an obese child should begin with: 
•  Detailed medical examination 
•  Assessment of diet 
•  Assessment of physical activity and behaviors that are linked to obesity Nutrients  2009, 1                                       
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•  Appraisal of the degree of obesity and its associated metabolic complications 
-  Assessment of obesity/adiposity: 
•  Body composition assessment/measurements: from height and weight, BMI 
(kg/m
2), skinfold thickness and waist circumferences.  
•  Assessment of fat, fat free mass, and bone mineral content using laboratory 
techniques (i.e., BIA, Dual energy X-ray Absorptiometry (DXA), computed 
tomography (CT), Magnetic Resonance Imaging (MRI). 
-  Assessment of Obesity – related diseases: 
•  Laboratory tests, (glucose, insulin, lipid profile, thyroid function, appropriate 
hormones, hepatic function), blood pressure assessment 
-  Specialized treatments – programs and interventions 
•  Dietary components 
•  Physical exercise 
•  Pharmacologic approaches 
•  Surgical approaches 
•  Primary and specialized care 
 
Comments 
 
It is important to establish objective evidence of the beneficial impact of any preventive and/or 
treatment program. To stop the epidemic of childhood obesity, it is mandatory to act at different levels 
including medical, social, educational and political [9]. A broad range of action would include 
establishing good nutrition education campaigns, regulating marketing of junk food, eliminating 
energy-dense food and sodas from being sold in schools and strongly promoting physical activity.  
Ultimately, we reemphasize the importance of early intervention in preventing the medical and 
psychosocial sequelae of obesity, as well as the persistence of obesity into adulthood. This underlines 
the need for increased awareness and identification of obesity in the primary care setting, especially 
among younger children. 
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